calan tablet
- Dr. Nabeera
- May 1
- 3 min read
کیلن گولی
Written by Dr. Nabeera [PharmD, DOW University Of Health Sciences (DUHS)], Karachi, Pakistan.

Brand name:
Calan
Generic name:
Verapamil HCl
Available dosage forms and their doses:
Available in tablet form in 40 mg and 80 mg doses.
Price:
40 mg 1 bottle, which contains 50 tablets, price is Rs. 172.5
80 mg tablet box
240 mg tablet box (calan SR)
Therapeutic class:
Calcium channel blocker (non-dihydropyridine)
Pharmacological class:
L-type calcium channel blocker in the heart and blood vessels.
Manufacturer:
The Searle Company Ltd
Storage:
To be stored below 30 degrees Celsius.
Protect from light, moisture, and heat.
Keep out of children’s reach.
Prescription drug?
Yes
Mechanism of action:
Inhibition of calcium ion influx through channels into conductive and contractile myocardial cells and vascular smooth muscle cells.
Indications and dosages:
Hypertension (mild to moderate)
Renal hypertension
Management and prophylaxis of Angina Pectoris
Treatment and management of paroxysmal supraventricular tachycardia
To reduce the ventricular rate in atrial fibrillation/flutter
For Hypertension:
Initially, 120 mg two times a day, increasing to 160 mg two times a day (if necessary). For
some cases, up to 480 mg daily divided dose is also used.
For Angina:
120 mg three times a day. If patients have angina of effort, then an 80 mg dose three times a day can also be sufficient. For variant angina, less than 120 mg three times a day may not be effective.
Supraventricular tachycardia:
40-120 mg three times a day.
Pediatric population:
Up to 2 years: 20 mg two to three times a day.
Above 2 years: 40-120 mg two to three times a day.

Elderly: -
The above-recommended dose, unless they have renal or liver function impairment.
Side effects:
Immune system disorders: allergic reactions
Nervous system disorders: headache, dizziness, paraesthesia, tremor,
extrapyramidal syndrome, dystonia
Ear and labyrinth disorders: vertigo, tinnitus
Cardiac disorders: bradycardic, arrhythmias, 2nd, and 3rd-degree AV block,
palpitations, tachycardia, development of heart failure, hypotension
Vascular disorders: flushing, peripheral edema
GI disorders: nausea, vomiting, constipation, ileus, abdominal pain
Skin and subcutaneous tissue disorders: alopecia, ankle edema, Quincke’s
edema, Steven-Johnson syndrome, erythema multiforme, erythromelalgia,
purpura
Musculoskeletal and connective tissue disorder: muscle weakness, myalgia and
arthralgia
Reproductive system and breast disorder: erectile dysfunction, gynaecomastia
General disorder: Fatigue
Interactions:
Alcohol
Acetyl salicylic acid
Alpha-blockers (Prazosin and Terazosin)
Antiarrhythmics (Flecainide, Quinidine,
Anticonvulsants (Carbamazepine and Phenytoin)
Antidepressants (Imipramine)
Antidiabetics (Glibenclamide)
Antihypertensives, diuretics, and vasodilators
Anti-infectives (Rifampicin, Erythromycin, Clarithromycin, Telithromycin)
Antineoplastics (Doxorubicin)
Barbiturates (Phenobarbital)
Benzodiazepines and other anxiolytics (Buspirone and Midazolam)
Beta-blockers (Metoprolol and Propranolol)
Cardiac glycoside (Digitoxin and Digoxin)
Colchicine
H2 receptor antagonist (Cimetidine)
HIV antiviral agents (Ritonavir)
Immunosuppressants (Ciclosporin, Everolimus, Sirolimus, and Tacrolimus)
Inhaled anesthetics
Lipid-lowering agents (Atorvastatin, Simvastatin and Lovastatin)
Lithium
Metformin
Neuromuscular blocking agents
Serotonin receptor agonists (Almotriptan)
Theophylline
Uricosurics (Sulfinpyrazone)
Anticoagulants (Dabigatran etexilate)
Other cardiac therapy (Ivabradine)
Others (St. John’s Wort and Grapefruit)

Pregnancy:
Avoid in the first trimester, unless essential.
Lactation:
Only use if essential, otherwise, avoid.
Precautions:
For patients with liver disease, careful dose titration is recommended.
For renal impairment patients, monitoring should be done.
For patients with bradycardia or first-degree AV block, it should be used with
caution.
For patients with incipient cardiac failure, Verapamil should be given only after
controlling cardiac failure.
For hypertension treatment, the blood pressure should be monitored at regular
intervals.
For patients taking HMG CoA reductase inhibitors, caution should be exercised.
Start with the lowest possible dose.
For patients with neuromuscular transmission diseases, caution should be
exercised.




Comments